Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: A systematic review

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2634-2646

  Puñal, Jeannete ^a   Lema, Leonor Varela ^a   Sanhez Guisande, Domingo ^b   Ruano Ravina, Alberto ^a,c,d  

^a Galician Agency for Health Technology Assessment   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Daily haemodialysis; End stage renal disease; MeSH terms: renal replacement therapy; Renal dialysis; Systematic review

Indexed keywords

7 (3 FORMYLBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID 4 PHENYLSEMICARBAZONE; ANTIHYPERTENSIVE AGENT;

ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; HEALTH SURVEY; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY FAILURE; MORBIDITY; NUTRITIONAL STATUS; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; VASCULAR ACCESS;

ANEMIA; ANTIHYPERTENSIVE AGENTS; CATHETERS, INDWELLING; ERYTHROPOIETIN, RECOMBINANT; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; NUTRITIONAL STATUS; QUALITY OF LIFE; RENAL DIALYSIS; SAFETY; TREATMENT OUTCOME;

EID: 48749096721     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn010     Document Type: Article

References (69)

1. National Kidney Foundation. K/DOQI clinical guidelines for hemodialysis adequacy. Am J Kidney Dis 2000; 37(Suppl 1): S7-S64
2. Otero A, Gayoso P, García F et al. Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE Study. Kidney Int 2005; 68(Suppl 99): S1-S4
3. ERA-EDTA Registry: ERA-EDTA Registry 2003 Annual Data Report Internet. Academic Medical Center, Amsterdam, May 2005. Available from http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2003.pdf
4. Shinaberger JH. Quantification of dialysis: historical perspective. Semin Dial 2001; 14: 238-245
5. Varela Lema L, Ruano-Ravina A. Effectiveness and safety of different hemodialysis modalities: a review. J Nephrol 2007; 20: 525-542
6. Varela Lema L, Ruano Raviña A. Efectividad y seguridad de las diferentes variantes de hemodiálisis y hemofiltración. Santiago de Compostela: Servicio Galego de Saúde, Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia, avalia-t, 2005. Series Avaliación de Tecnoloxías. Informe de avaliación: INF2005/03
7. Charra B, Chazot C, Jean G et al. Long, slow dialysis. Miner Electrolyte Metab 1999; 25: 391-396
8. Varela Lema L, Ruano Raviña A. Desarrollo y utilización de una escala de valoración de calidad construida específicamente para evaluar estudios que comparen modalidades de hemodiálisis. Nefrología 2006; 26: 98-107
9. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: Wiley, 1986
10. Wiley J, Fleiss JL. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973; 33: 613-619
11. Reynolds JT, Homel P, Cantey L et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif 2004; 22: 320-328
12. Buoncristiani U, Fagugli RM, Pinciaroli MR et al. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD). Contrib Nephrol 1996; 119: 152-156
13. Floridi A, Antolini F, Galli F et al. Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002; 17: 871-878
14. Galland R, Traeger J, Arkouche W et al. Short daily hemodialysis and nutritional status. Am J Kidney Dis 2001; 37(Suppl. 2): S95-S98
15. Fagugli R, Pasini P, Pasticci F et al. Effects of short daily hemodialysis and extend standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J Nephrol 2006; 19: 77-83
16. Pinciaroli AR. Hormonal changes in daily hemodialysis. Semin Dial 1999; 12: 455-461
17. Odar-Cederlöf I, Bjerllerup P, Williams A et al. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodial Int 2006; 10: 394-398
18. Martins Castro MC, Luders C, Motta Elias R et al. High-efficiency short daily haemodialysis. Morbidity and mortalityrate in a long-term study. Nephrol Dial Transplant 2006; 21: 2232-2238
19. Koshikawa S, Akizawa T, Saito A et al. Clinical effect of short daily in-center hemodialysis. Nephron Clin Pract 2003; 95: c23-30
20. Piccoli GB, Bermond F, Mezza E et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 2004; 19: 2084-2094
21. Ting G, Kjellstrand C, Freitas T et al. Long-term study of high-comorbidity ESRD patients converted From conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42: 1020-1035
22. Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N et al. A crossover study of short daily haemodialysis. Nephrol Dial Transplant 2006; 21: 166-175
23. Williams AW, Chebrolu SB, Ing TS et al. Early clinical, quality-of-life, and biochemical changes of "Daily hemodialysis" (6 dialyses per week). Am J Kidney Dis 2004; 43: 90-102
24. Traeger J, Galland R, Delawari E et al. Six years' experience with short daily hemodialysis: Do the early improvements persist in the mid and long term? Hemodial Int 2004; 8: 151-158
25. Nesrallah G, Suri R, Zoller R et al. The international quotidian dialysis registry: annual report 2006. Hemodial Int 2006; 10: 219-224
26. Ayus JC, Mizani MR, Achinger SG et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005; 16: 2778-2788
27. Yuen D, Richardson RMA, Chan CT. Improvements in phosphate control with short daily in-center hemodialysis. Clin Nephrol 2005; 64: 364-370
28. Galland R, Traeger J. Short daily hemodialysis and nutritional status in patients with chronic renal failure. Semin Dial 2004; 17: 104-108
29. Churchill DN, Taylor DW, Cook RJ et al. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992; 19: 214-234
30. De Marchi S, Falleti E, Giacomello R et al. Risk factor for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 1996; 7: 1169-1177
31. Feldman HI, Held PJ, Hutchinson JT et al. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-1096
32. Goldwasser P, Michel MA, Collier J et al. Prealbumin and lipoprotein (a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993; 22: 215-225
33. Windus DW, Jendrisak MD, Delmez J. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992; 19: 448-452
34. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998; 13(Suppl 6): 148-151
35. Woods JD, Port FK, Orzol S et al. Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999; 55: 2467-2476
36. Quintaliani G, Buoncristiani U, Fagugli R et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000; 53: 372-377
37. Fagugli RM, Vanholder R, De Smet R et al. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis. Int J Artif Organs 2001; 24: 256-262
38. Lai K, Yin J, Yuen P et al. Effect of hemodialysis on protein C, protein S, and antithrombin III levels. Am J Kidney Dis 1991; 17: 38-42
39. Twardowski Z, Lebek R, Kubara H. 6-Year experience with the creation and use of internal arteriovenous fistulae in patients treated with repeated hemodialysis. Pol Arch Med Wewn 1977; 57: 205-214
40. Friedman AN, Bostom AG, Levey AS et al. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 2002; 13: 265-268
41. Fagugli R, Reboldi G, Quintaliani G et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-376
42. Nesrallah G, Suri R, Moist L et al. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003; 42(Suppl 1): S13-S17
43. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
44. Ishimura E, Taniwaki H, Tabata T et al. Cross-sectional association of serumphosphate with carotid intima-medial thickness in hemodialysis patients. Am J Kidney Dis 2005; 45: 859-865
45. Galland R, Traeger J, Delawari E et al. Daily hemodialysis versus standard hemodialysis: TAC, TAD, weekly eKt/V, std(Kt/V), and nPCR. Home Hemodial Int 1999; 3: 33-36
46. Fagugli RM, Buoncristiani U, Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs 1998; 21: 429-431
47. Spanner E, Suri R, Heidenheim AP. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003; 2: 30-35
48. Galland R, Traeger J, Arkouche W et al. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001; 60: 1555-1560
49. Traeger J, Galland R, Arkouche W et al. Short daily hemodialysis: a four-year experience. Nephrol Dial Transplant 2001; 30: 78-86
50. Pinciaroli AR. Results of daily hemodialysis in Cantarazo: 12 years experience with 22 patients treated for more than one year. Home Hemodial Int 1998; 2: 12-17
51. Makita Z, Bucala R, Rayfield EJ. Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet 1994; 343: 1519-1522
52. Miyata T, Iada Y, Horie K et al. Pathophysiology of advanced glycation end-products in renal failure. Nephrol Dial Transplant 1996; 11: 23-30
53. Bucala R. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implication for lipoprotein clearance and a atherogenesis. Nephrol Dial Transplant 1996; 11: 17-19
54. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223-234
55. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med 1996; 28: 419-426
56. Morbidity and mortality: USRDS 2005. Annual data report. Am J Kidney Dis 2006; 47(Suppl 1): S121-144
57. Depner T. Why daily hemodialysis is better: solute kinetics. Semin Dial 1999; 12: 462-471
58. Pierratos A. Nocturnal hemodialysis: an update on a five year experience. Nephrol Dial Transplant 1999; 14: 2835-2840
59. Buoncristiani E. Diálisis diaria ultracorta: el mejor sistema para disfrutar ventajosamente de altos aclaramientos. Nefrología 1999; 19(Suppl 4): 49-50
60. Harris DCH, Yuill EJ, Chester DW. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk. J Am Soc Nephrol 1995; 6: 1067-1612
61. Al-Hejaili F, Kortas C, Leitch R. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14: 2322-2328
62. Hou SH, Zhao J, Ellman CF. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991; 18: 217-224
63. Albalate M, De la Piedra C, Fernandez C. Association between phosphate removal and markers of bone turnover in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 1626-1632
64. Ayus JC, Achinger SG, Mizani MR et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 2006; 27: 1-7
65. Lindsay RM. The London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial 2004; 17: 85-91
66. Heidenheim AP, Muirhead N, Moist L et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42(Suppl 1): 36-41
67. Halpern SD, Berns JS, Israni AK. Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap. Am J Med 2004; 116: 606-612
68. Israni AK, Halpern SD, McFadden C et al. Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis. Kidney Int 2004; 65: 990-998
69. Piccoli GB, Ladarola AM, Bechis F et al. La dialisi quotidiana: valutazione del primo anno di esperienza a domocilio ed in unh centro ad assistenza limitata. Minerva Urol Nefrol 2002; 54: 1-7